These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 9552442)
1. Sustained release of acetaminophen from heterogeneous matrix tablets: influence of polymer ratio, polymer loading, and co-active on drug release. Ebube NK; Hikal AH; Wyandt CM; Beer DC; Miller LG; Jones AB Pharm Dev Technol; 1997 May; 2(2):161-70. PubMed ID: 9552442 [TBL] [Abstract][Full Text] [Related]
2. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers. Ebube NK; Jones AB Int J Pharm; 2004 Mar; 272(1-2):19-27. PubMed ID: 15019065 [TBL] [Abstract][Full Text] [Related]
3. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen. Cao QR; Choi YW; Cui JH; Lee BJ J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656 [TBL] [Abstract][Full Text] [Related]
4. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation. Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270 [TBL] [Abstract][Full Text] [Related]
5. Formulation study and drug release mechanism of a new theophylline sustained-release preparation. Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302 [TBL] [Abstract][Full Text] [Related]
6. Comparison of a novel fast-dissolving acetaminophen tablet formulation (FD-APAP) and standard acetaminophen tablets using gamma scintigraphy and pharmacokinetic studies. Wilson CG; Clarke CP; Starkey YY; Clarke GD Drug Dev Ind Pharm; 2011 Jul; 37(7):747-53. PubMed ID: 21244275 [TBL] [Abstract][Full Text] [Related]
7. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone. Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477 [TBL] [Abstract][Full Text] [Related]
8. Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates. Nerurkar J; Jun HW; Price JC; Park MO Eur J Pharm Biopharm; 2005 Sep; 61(1-2):56-68. PubMed ID: 15893919 [TBL] [Abstract][Full Text] [Related]
9. Substituted amylose matrices for oral drug delivery. Moghadam SH; Wang HW; Saddar El-Leithy E; Chebli C; Cartilier L Biomed Mater; 2007 Mar; 2(1):S71-7. PubMed ID: 18458424 [TBL] [Abstract][Full Text] [Related]
10. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets. Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223 [TBL] [Abstract][Full Text] [Related]
11. Bead compacts. I. Effect of compression on maintenance of polymer coat integrity in multilayered bead formulations. Altaf SA; Hoag SW; Ayres JW Drug Dev Ind Pharm; 1998 Aug; 24(8):737-46. PubMed ID: 9876521 [TBL] [Abstract][Full Text] [Related]
12. Development of theophylline sustained release dosage form based on Kollidon SR. Reza MS; Quadir MA; Haider SS Pak J Pharm Sci; 2002 Jan; 15(1):63-70. PubMed ID: 16414869 [TBL] [Abstract][Full Text] [Related]
13. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets. Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243 [TBL] [Abstract][Full Text] [Related]
14. Two different approaches for the prediction of in vivo plasma concentration-time profile from in vitro release data of once daily formulations of diltiazem hydrochloride. Bendas ER Arch Pharm Res; 2009 Sep; 32(9):1317-29. PubMed ID: 19784589 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC. Shoaib MH; Tazeen J; Merchant HA; Yousuf RI Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122 [TBL] [Abstract][Full Text] [Related]
16. Analgesic efficacy and safety of tramadol/ acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial. Peloso PM; Fortin L; Beaulieu A; Kamin M; Rosenthal N; J Rheumatol; 2004 Dec; 31(12):2454-63. PubMed ID: 15570651 [TBL] [Abstract][Full Text] [Related]
17. Oral matrix tablet formulations for concomitant controlled release of anti-tubercular drugs: design and in vitro evaluations. Hiremath PS; Saha RN Int J Pharm; 2008 Oct; 362(1-2):118-25. PubMed ID: 18640251 [TBL] [Abstract][Full Text] [Related]
18. A study on maize proteins as a potential new tablet excipient. Georget DM; Barker SA; Belton PS Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824 [TBL] [Abstract][Full Text] [Related]
19. Parameters affecting the drug release from in situ gelling nasal inserts. Bertram U; Bodmeier R Eur J Pharm Biopharm; 2006 Jul; 63(3):310-9. PubMed ID: 16513333 [TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery. Reza MS; Quadir MA; Haider SS J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]